Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: A substudy of the CHARISMA trial

International Journal of Stroke

Volumn 6, Issue 1, 2011, Pages 3-9

  Hankey, Graeme J ^a   Johnston, S Claiborne ^b   Easton, J Donald ^c   Hacke, Werner ^d   Mas, Jean Louis ^e   Brennan, Danielle ^f   Mak, Koon Hou ^g   Bhatt, Deepak L ^h   Fox, Keith A A ⁱ   Topol, Eric J ^j  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UCSF Neurology   (United States)

^c BROWN UNIVERSITY   (United States)

^d Neurology Department   (Germany)

^e CENTRE HOSPITALIER SAINTE ANNE   (France)

^f LERNER RESEARCH INSTITUTE   (United States)

^g GLENEAGLES HOSPITAL   (Singapore)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^j SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

more..

Author keywords

Antiplatelet therapy; Aspirin; Atherothrombotic; CHARISMA; Clinical trial; Clopidogrel; Ischaemic stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HYPOTHESIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSIENT ISCHEMIC ATTACK;

AGED; ASPIRIN; BRAIN ISCHEMIA; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; SAMPLE SIZE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 78650963493     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00535.x     Document Type: Article

References (17)

1. Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006; 5:323-31.
2. Johnston SC, Rothwell PM, Nguyen-Huynh MN et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283-92.
3. Van Wijk I, Kappelle LJ, van Gijn J et al, for the LiLAC study group. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 2005; 365:2098-104.
4. Sandercock PAG, Counsell C, Gubitz GJ, Tseng MC. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD000029, doi: DOI: 10.1002/14651858.CD000029.pub2.
5. Algra A, van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischemia of arterial origin. J Neurol Neurosurg Psychiatry 1999; 66:255.
6. Dengler R, Diener H-C, Schwartz A et al. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010; 9:159-66.
7. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-Segment elevation. N Engl J Med 2001; 345:494-502.
8. Sabatine MS, Cannon CP, Gibson CM et al, for the CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005; 352:1179-89.
9. Markus HS, Droste DW, Kaps M, Larrue V, Lees K, Siebler M, Ringelstein EB. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection. The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis (CARESS) trial. Circulation 2005; 111:2233-40.
10. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364:331-7.
11. Kennedy J, Hill MD, Ryckhorst K, Eliaszaw M, Demchuk AMBuchan AM for the FASTER investigators. Fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER) - a randomised controlled pilot study. Lancet Neurol 2007; 6:961-9.
12. Bhatt DL, Topol Eon behalf of the CHARISMA Executive Committee. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the CHARISMA trial. Am Heart J 2004; 148:263-8.
13. Bhatt DL, Fox KA, Hacke W et al, for the CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354:1706-17.
14. Bhatt DL, Flather MD, Hacke W et al, for the CHARISMA Investigators. Patients with prior myocardial infarction, stroke or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 2007; 49:1982-8.
15. Available at (accessed 25 February 2010) and (accessed 25 February 2010).
16. Available at (accessed 25 February 2010) and (accessed 25 February 2010).
17. Available at (accessed 25 February 2010).